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Abstract
Purpose To evaluate the performance of the NoSAS (neck, obesity, snoring, age, sex) score, the STOP-Bang (snoring, tiredness,
observed apneas, blood pressure, body mass index, age, neck circumference, gender) questionnaire, and the Epworth sleepiness
score (ESS) as a screening tool for obstructive sleep apnea (OSA) severity based on the apnea-hypopnea index (AHI) and the
oxygen desaturation index (ODI).
Methods Data from 235 patients who were monitored by ambulant polysomnography (PSG) were retrospectively analyzed.
OSA severity was classified based on the AHI; similar classification categories were made based on the ODI. Discrimination was
assessed by the area under the curve (AUC), while predictive parameters were calculated by four-grid contingency tables.
Results The NoSAS score and the STOP-Bang questionnaire were both equally adequate screening tools for the AHI and the
ODI with AUC ranging from 0.695 to 0.767 and 0.684 to 0.767, respectively. Both questionnaires perform better when used as a
continuous variable. The ESS did not show adequate discrimination for screening for OSA (AUC ranging from 0.450 to 0.525).
Male gender, age, and BMI proved to be the strongest individual predictors in this cohort.
Conclusion This is the first study to evaluate the predictive performance of three different screening instruments with respect to
both the AHI and the ODI. This is important, due to increasing evidence that the ODI may have a higher reproducibility in the
clinical setting. The NoSAS score and the STOP-Bang questionnaire proved to be equally adequate to predict OSA severity
based on both the AHI and the ODI.
Keywords Obstructive sleep apnea . Polysomnography .
Screening . NoSAS score . STOP-Bang questionnaire . ESS
Introduction
Obstructive sleep apnea (OSA) is a sleep-related breathing dis-
order characterized by repetitive partial or complete upper airway
obstruction which often results in decreased arterial oxygen sat-
uration and arousal from sleep [1]. OSA severity is commonly
classified based on the apnea-hypopnea index (AHI) [2]. OSA
has been associated with cardiovascular and metabolic conse-
quences and is also linked with increased overall mortality [3].
Currently, overnight polysomnography (PSG) is the gold stan-
dard for diagnosing the presence and severity of OSA. However,
its high expense, relative inaccessibility, and time consumption
can delay or impede the diagnosis and treatment of patients with
OSA, mainly in areas with limited healthcare resources [4].
Additionally, the increasing number of patients suspected of hav-
ing OSA and the lack of structured patient interviews contribute
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to the growing number of patients being referred to sleep clinics
[5]. Therefore, simple screening instruments for identifying pa-
tients at high risk for OSA have become increasingly important.
Several instruments have been developed over the years in-
cluding the STOP-Bang questionnaire [6, 7] and the NoSAS
score [8]. The STOP-Bang questionnaire shows a high sensitivity
and negative predictive value, and therefore is a suitable instru-
ment to rule out patients at risk for OSA [9–12]. However, it has
a low to moderate specificity and it is possible that this will yield
a high false-positive rate. Low specificity may result in unneces-
sary referral to sleep clinics for polysomnography [6, 7]. The
NoSAS score has been validated in multiple patient cohorts,
and opinions concerning superiority over the STOP-Bang ques-
tionnaire differ [8, 10, 13–15]. The original validation of the
NoSAS score by Marti-Soler et al. describes higher specificity
and positive predictive values in comparison with the STOP-
Bang questionnaire, while maintaining a moderate to high sensi-
tivity and negative predictive value, therefore allowing to rule out
clinically significant OSA and simultaneously reducing the num-
ber of unnecessary nocturnal recordings as well as the number of
missed diagnosis [8]. The Epworth sleepiness scale (ESS), which
was originally designed to assess the extent of daytime sleepi-
ness, has also been suggested as a screening tool for identifying
patients at high risk for OSA [16]. However, multiple authors
have found the ESS to be inferior to other screening tools for
identifying patients at high risk for OSA [11, 12, 17, 18].
The present study reviewed and analyzed a cohort of
235 patients who underwent PSG, using in each case all
three instruments: the STOP-Bang questionnaire [6], the
NoSAS score [8], and the ESS [16]. Our main objectives
were to evaluate the predictive and discriminative perfor-
mance of the different screening instruments and com-
pare the diagnostic effectiveness of the different
methods. Additionally, we aimed to determine which
variables independently were the strongest predictors in
this cohort.
Recently, it has been suggested that the AHI is susceptible to
variability in the clinical setting and that there is a need for an
alternative parameter to indicate OSA severity [3, 19–21]. An
important disadvantage regarding the AHI is that the morpholo-
gy and duration of the apneas are not taken into account. Longer,
deeper apneas might be more significant than shorter, shallow
ones [22]. Significant differences in the severity of OSA have
been described between patients with a similar AHI [22].
Nocturnal oxygen desaturations are the result of apneas and are
important in the pathogenesis and development of complications
of OSA [23]. The arterial oxygen desaturation index (ODI) has
therefore been proposed as an alternative for the AHI in grading
PSG data and classifying OSA severity [23–26]. The ODI might
be more relevant due to the higher reproducibility in the clinical
setting [3, 19–21]. Furthermore, there is evidence that the ODI is
independently associated with prevalent risk factors like hyper-
tension, whereas the AHI is not [19]. Therefore, in the present
study, the discriminatory ability of the screening instruments will
be evaluated by criteria based on the AHI as well as on the ODI.
Methods
Study design
Data from 235 patients who were monitored by ambulant
PSG were retrospectively analyzed. Patient inclusion
criteria were patients aging 18 years of age or older, com-
pleted clinical data, and completed STOP-Bang question-
naire and NoSAS score. Patient exclusion criteria were
previously diagnosed OSA, use of portable sleep studies
or respiratory polygraphy, incomplete clinical data, and
technically inadequate PSG. In the outpatient clinic, the
following clinical parameters were collected for all pa-
tients: gender, age, height, weight, body mass index
(BMI), neck circumference (NC), self-reported complaints
(snoring, daytime sleepiness, and apnea), and self-
reported comorbidities (cardiovascular history, hyperten-
sion, pulmonary history). The ESS was completed. The
clinical parameters were used to calculate the NoSAS
score and the STOP-Bang questionnaire.
Screening instruments (supplementary material)
The STOP-Bang questionnaire consists of four questions
used in the STOP questionnaire—snoring, tiredness, ob-
served apneas, and hypertension—plus four demographic
queries—BMI > 35 kg/m2, age > 50 years old, neck cir-
cumference > 40 cm, and male gender. For each question,
answering ‘yes’ scores 1, a ‘no’ scores 0. With a total
range of 0–8, a total score of ≥ 3 points is considered as
a high probability for OSA [6]. The NoSAS score is a 5-
item questionnaire which includes neck circumference,
obesity, snoring, age, and gender. With a range of 0–17,
NoSAS scores 4 points for neck circumference ≥ 40 cm, 3
points for BMI 25–30 kg/m2, 5 points for BMI ≥ 30 kg/
m2, 2 points for snoring, 4 points for age > 55 years old,
and 2 points for male gender. The total score of ≥ 8 points
is considered as a high probability for OSA [8]. The ESS
consists of 8 situations, allowing the patients to assess
their degree of dozing off or falling asleep in a particular
scene during the day, 0 for no dozing, and 1, 2, and 3 for
slight, moderate, and high chance of dozing. A total score
of ≥ 10 points is considered as excessive daytime sleepi-
ness [16].
Sleep study, scoring, and diagnosis
All patients underwent a full-night PSG at home. PSG
included electroencephalography, electrooculography,
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surface electromyography, nasal airflow and air tempera-
ture, thoracoabdominal movements, pulse oximetry, body
position, and snoring sounds. Breathing was recorded
with nasal pressure and temperature sensors. Scoring of
the electronic raw data was performed manually, follow-
ing the recommendations of the American Academy of
Sleep Medicine [2]. Apnea was defined as a decrease of
at least 90% of airflow from baseline for > 10 s.
Hypopnea was defined as a decrease of at least 30% of
airflow from baseline for > 10 s, associated with either an
arousal or ≥ 3% arterial oxygen saturation decrease. The
mean number of apneas and hypopneas per hour of sleep
(AHI) was calculated. The ODI was defined as the mean
number of arterial oxygen desaturations ≥ 3% per hour.
The severity of OSA was categorized both according to
the AHI and to the ODI. By using the AHI, patients were
classified as mild (5 ≤AHI < 15 events/h), moderate (15 ≤
AHI < 30 events/h), or severe (AHI ≥ 30 events/h) accord-
ing to the 2012 American Academy of Sleep Medicine
criteria [2]. For classification according to the ODI, pa-
tients were divided into similar groups: mild (5 ≤ODI <
15 events/h), moderate (15 ≤ODI < 30 events/h), and se-
vere (ODI ≥ 30 events/h) [27]. Other PSG parameters col-
lected included the apnea index (AI), the AHI in supine
position, the AHI in non-supine position, minimal arterial
oxygen saturation (minimal SpO2), baseline arterial oxy-
gen saturation (baseline SpO2), average arterial oxygen
saturation (average SpO2), and percentage of sleep time
with arterial oxygen saturation time below 90% (SpO2
time < 90%).
Statistical analysis
The statistical analysis was performed by using Statistical
Package for Social Studies (IBM SPSS Statistics version 24
for Windows, New York, NY, USA). Continuous data are pre-
sented as means with standard deviations. Categorical variables
are presented as frequencies with percentages. Comparisons be-
tween groups were performed using Chi-square tests for cate-
gorical variables, unpaired Student’s t test, and univariate anal-
ysis of variance (ANOVA) for continuous variables.
Discrimination, the ability of a screening tool to distinguish
between patients with and without different outcomes, was es-
timated from the area under the curve (AUC) obtained by re-
ceiver operator characteristic (ROC) curves, which may range
from 0.5 (no discrimination) to 1.0 (perfect discrimination) [28].
The AUCs were compared using the algorithm previously de-
scribed by Hanley et al. [29]. Additionally, sensitivity, specific-
ity, positive predictive value (PPV), and negative predictive val-
ue (NPV) were calculated for different AHI and ODI cutoffs
using four-grid contingency tables, all estimates are reported
with their respective 95% confidence interval (CI). The associ-
ation between various individual demographic and clinical
variables and the presence and degree of OSA was established
by using a multivariate logistic regression model (backward




A total of 201 patients met our inclusion criteria; baseline
characteristics are mentioned in Table 1. A total of 148
(73.6%) patients were male, aged 50.0 ± 12.6 years, with a
mean BMI of 28.0 ± 4.8 kg/m2. Based on the AHI, OSA
was present in 159 (79.1%) of the patients; 66 (41.5%) with
mild OSA, 45 (28.3%) with moderate OSA, and 48 (30.2%)
with severe OSA. Male gender, age, BMI, neck circumfer-
ence, cardiovascular history, hypertension, snoring, and ap-
neas were all significantly higher in the OSA groups than in
the no OSA group. A post hoc Bonferroni test showed a sta-
tistically significant difference between no OSA and
moderate/severe OSA for male gender (p = 0.008; p =
0.001), age (p = 0.002; p = 0.013), and BMI (p = 0.045;
p < 0.001). BMI was also significantly different between
mild/moderate OSA and severe OSA (p < 0.001; p = 0.030).
Neck circumference (p = 0.043; p = 0.032), cardiovascular
history (p = 0.006; p = 0.040), and hypertension (p = 0.004;
p = 0.002) all showed a statistically significant difference be-
tween no/mild OSA and severe OSA. The ESS did not differ
significantly between OSA groups (p = 0.667; p = 0.616). A
total of 54.5%, 75.6%, and 85.4% of the patients in the mild,
moderate, and severe OSA group, respectively, were classi-
fied as high risk of OSA according to the NoSAS score (cutoff
≥ 8; p < 0.001). A total of 97%, 100%, and 100% in the mild,
moderate, and severe OSA group, respectively, were classi-
fied as high risk of OSA according to the STOP-Bang ques-
tionnaire (cutoff ≥ 3; p < 0.001). Polysomnography results
(AHI, ODI ≥ 3%, minimal SpO2, average SpO2, and SpO2
time < 90%) were all significantly different between the
OSA and no OSA groups (p < 0.001; p < 0.001; p < 0.001;
p < 0.001; p = 0.001). Notable is the percentage of patients
with positional sleep apnea which was also statistically signif-
icant between the groups (p < 0.001). A post hoc Bonferroni
test shows that the difference was significant between no OSA
and all OSA severity groups (p < 0.001) and mild OSA and
severe OSA (p = 0.05).
Performance of instruments
The predictive performance of the different screening instru-
ments as categorical variable is shown in Table 2. For screen-
ing on different cut-off points of AHI and ODI severity, the
sensitivity of the NoSAS score varies from 0.70 to 0.92
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(AHI > 5 and AHI > 15, respectively). The specificity varies
from 0.37 to 0.55 (AHI > 15 and AHI > 5, respectively). The
STOP-Bang questionnaire showed the highest sensitivity
varying from 0.99 to 1.00. However, the specificity was lower
varying from 0.06 to 0.17. The highest specificity was obtain-
ed by the ESS, varying from 0.79 to 0.83, with a low sensi-
tivity varying from 0.15 to 0.19. Figure 1 shows the ROC
curves and the corresponding AUC of the three screening
instruments on different levels of AHI and ODI severity.
The screening instruments are presented as continuous vari-
ables. The ESS did not show adequate discrimination for
screening for AHI and ODI with an AUC ranging from
0.450 to 0.525. The NoSAS score and the STOP-Bang ques-
tionnaire were both equally adequate screening tools for the
AHI and the ODI with AUC ranging from 0.695 to 0.767 and
0.684 to 0.767, respectively (all comparisons with p value >
0.05). The discriminatory ability of the NoSAS score and the
STOP-Bang questionnaire was similar in relation to both the
AHI and the ODI (all comparisons with p value > 0.05).When
used as categorical variable, the AUC of the NoSAS score
ranged from 0.620 to 0.684 (cutoff ≥ 8), the AUC of the
STOP-Bang questionnaire ranged from 0.529 to 0.577 (cutoff
≥ 3) (Table 2). Both instruments performed better when used
as continuous variable than as categorical variable. However,
only for the STOP-Bang questionnaire, this difference proved
to be significant (all comparisons except AHI ≥ 5 with p value
< 0.05).
Predicting OSA
Multivariate logistic regression analyses were performed in
order to establish the association between various individual
demographic and clinical variables and the presence and de-
gree of OSA categorized by the AHI and the ODI. Gender,
Table 1 Baseline characteristics




(5 ≤AHI < 15)
(n 66)
Moderate OSA






Male patients 148 (73.6%) 22 (52.4%) 47 (71.2%) 37 (82.2%) 42 (87.5%) 0.001
Age (year) 50.0 ± 12.6 44.3 ± 11.0 49.3 ± 11.8 54.0 ± 11.0 52.3 ± 13.7 0.002
BMI (kg/m2) 28.0 ± 4.8 25.9 ± 3.4 26.7 ± 4.2 28.5 ± 4.0 31.1 ± 5.8 < 0.001
NC> 40 (cm) 100 (49.8%) 17 (40.5%) 28 (42.4%) 22 (48.9%) 33 (68.8%) 0.020
Cardiovasc. His. 59 (29.4%) 6 (14.3%) 15 (22.7%) 16 (35.6%) 22 (45.8%) 0.004
Hypertension 46 (22.9%) 5 (11.9%) 9 (13.6%) 12 (26.7%) 20 (41.7%) 0.001
Pulm. His. 7 (3.5%) 3 (7.1%) 1 (1.5%) 0 (0%) 3 (6.3%) 0.813a
Snoring 190 (94.5%) 38 (90.5%) 61 (92.4%) 43 (95.6%) 45 (100%) 0.033a
Sleepiness 166 (82.6%) 38 (90.5%) 50 (75.8%) 37 (82.2%) 41 (85.4%) 0.238
Apneas 148 (73.6%) 27 (64.3%) 43 (65.2%) 36 (80.0%) 42 (87.5%) 0.018
ESSb 5.8 ± 3.6 6.1 ± 3.9 5.4 ± 3.6 5.6 ± 3.4 6.1 ± 3.6 0.667
ESS ≥ 10b 35 (17.4%) 9 (21.4%) 12 (19.4%) 5 (11.4%) 9 (19.6%) 0.616
NoSAS 9.5 ± 4.0 7.3 ± 3.9 8.6 ± 3.5 10.3 ± 3.6 12.0 ± 3.5 < 0.001
NoSAS ≥ 8 130 (64.7%) 19 (45.2%) 36 (54.5%) 34 (75.6%) 41 (85.4%) < 0.001
Stop-Bang 4.6 ± 1.4 3.8 ± 1.4 4.2 ± 1.2 4.8 ± 1.2) 5.5 ± 1.3 < 0.001
Stop-Bang ≥ 3 192 (95.5%) 35 (83.3%) 64 (97%) 45 (100%) 48 (100%) < 0.001a
AHI (e/h) 20.5 ± 18.8 3.2 ± 1.2 9.5 ± 3.0 22.2 ± 4.1 49.1 ± 18.8 < 0.001
ODI > 3% (e/h) 17.8 ± 17.3) 2.7 ± 1.4) 7.9 ± 3.3) 18.7 ± 5.2) 43.6 ± 14.5) < 0.001
Positional OSA 109 (54.2%) 0 (0%) 53 (80.3%) 30 (66.7%) 26 (54.2%) < 0.001
Min SpO2 (%) 84.8 ± 7.3 89.5 ± 3.4 87.1 ± 5.2 84.9 ± 3.9 77.6 ± 9.4 < 0.001
Average SpO2 (%) 94.1 ± 2.0 95.1 ± 1.6 94.3 ± 1.9 93.9 ± 1.6 93.2 ± 2.2 < 0.001
SpO2 time < 90% (%) 6.9 ± 14.8 3.0 ± 8.6 5.8 ± 17.2 4.5 ± 11.9 14.0 ± 15.9 0.001
Data are presented as mean ± standard deviation or number and percentage (%). Chi-square tests for categorical variables and ANOVA tests for
continuous variables
AHI apnea-hypopnea index, BMI body mass index, Cardiovasc. His. cardiovascular history, NC neck circumference, ODI oxygen desaturation index,
Pulm. His. pulmonary history
Italics is statistically significant
aMann-Whitney U test
b Seven missing patients
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age, and BMI proved to be the strongest predictors for any
OSA (AHI ≥ 5) (p < 0.001; p < 0.001; p = 0.004), moderate to
severe OSA (AHI ≥ 15) (p < 0.001; p < 0.001; p < 0.001),
ODI ≥ 5 (p = 0.001; p = 0.001; p = 0.001), and ODI ≥ 15
(p < 0.001; p < 0.001; p < 0.001). Gender, BMI, and self-
reported history of hypertension proved to be or the strongest
predictors for severe OSA (AHI ≥ 30) (p = 0.028; p < 0.001;
p = 0.028) and ODI ≥ 30 (p = 0.024; p < 0.001; p = 0.034).
The ROC curves of the estimated predictive probability, the
NoSAS score, and the STOP-Bang questionnaire with cutoff
points AHI ≥ 15 and ODI ≥ 15 are shown in Fig. 2. The AUC
of the estimated predicted probability was 0.784 when differ-
entiating for AHI ≥ 15 and 0.805 when differentiating for
ODI ≥ 15. The predicted probability performs similar to the
NoSAS score and the STOP-Bang questionnaire (all compar-
isons with p value > 0.05).
Discussion
The present study shows that both the NoSAS score and the
STOP-Bang questionnaire, but not the ESS, were equally use-
ful to detect patients at high risk for OSA. In this cohort, the
STOP-Bang questionnaire had the highest sensitivity, with a
low specificity. The NoSAS score had a higher specificity and
PPV, while maintaining a moderate to high sensitivity. The
ESS had the highest specificity, with a low sensitivity. This is
in correspondence with what was found by previous authors
[8, 10, 11, 13, 18, 30]. The discriminatory ability of the
NoSAS score and the STOP-Bang questionnaire was similar
in relation to both the AHI and the ODI. However, due to the
low specificity and positive predictive value of the STOP-
Bang questionnaire, it is possible that the STOP-Bang will
yield a large proportion of false-positive cases if used in a
wrong patient group and therefore increase the number of
unnecessary nocturnal recordings, whereas the NoSAS score
describes higher specificity and positive predictive values,
while maintaining a moderate to high sensitivity and negative
predictive value.
The discriminatory ability of the NoSAS score and the
STOP-Bang questionnaire as a categorical variable was com-
pared with the discriminatory ability as a continuous variable.
As expected, the discriminatory ability is higher when the
instrument is used as a continuous variable. However, only
for the STOP-Bang questionnaire, this difference proved to be
significant. Previous studies have already suggested that the
probability of moderate to severe OSA increases in direct
proportion to the STOP-Bang score, and therefore, the ques-
tionnaire should be used as a continuous rather than as a cat-
egorical variable. Chung et al. suggested patients with a
STOP-Bang score of 0 to 2 to be classified as being at low
risk for moderate to severe OSA. Those with a STOP-Bang
score of 5 to 8 can be classified as being at high risk for
moderate to severe OSA. In patients with a STOP-Bang score
Table 2 Performance of the NoSAS score, the STOP-Bang questionnaire, and the ESS. The screening instruments are presented as categorical
variables (NoSAS ≥ 8, STOP-Bang ≥ 3, ESS ≥ 10)
AUC (95% CI) Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI)
AHI ≥ 5 e/h NoSAS ≥ 8 0.623 (0.525–0.720) 0.70 (0.62–0.76) 0.55 (0.40–0.69) 0.85 (0.78–0.90) 0.32 (0.23–0.44)
STOP-Bang ≥ 3 0.577 (0.473–0.681) 0.99 (0.96–1.00) 0.17 (0.08–0.31) 0.82 (0.76–0.87) 0.78 (0.45–0.94)
ESS ≥ 10 0.478 (0.378–0.579) 0.16 (0.11–0.23) 0.79 (0.64–0.88) 0.74 (0.58–0.86) 0.2 (0.15–0.27)
AHI ≥ 15 e/h NoSAS ≥ 8 0.649 (0.573–0.725) 0.92 (0.85–0.96) 0.37 (0.29–0.46) 0.56 (0.48–0.63) 0.85 (0.72–0.93)
STOP-Bang ≥ 3 0.542 (0.462–0.621) 1.00 (0.96–1.00) 0.08 (0.04–0.15) 0.48 (0.41–0.55) 1.00 (0.70–1.00)
ESS ≥ 10 0.477 (0.395–0.558) 0.15 (0.09–0.24) 0.81 (0.72–0.97) 0.4 (0.26–0.56) 0.52 (0.45–0.6)
AHI ≥ 30 e/h NoSAS ≥ 8 0.636 (0.552–0.720) 0.85 (0.73–0.93) 0.42 (0.34–0.5) 0.32 (0.24–0.4) 0.9 (0.81–0.95)
STOP-Bang ≥ 3 0.529 (0.438–0.620) 1.00 (0.93–1.00) 0.06 (0.03–0.11) 0.25 (0.19–0.32) 1.00 (0.70–1.00)
ESS ≥ 10 0.510 (0.414–0.606) 0.19 (0.1–0.32) 0.83 (0.76–0.88) 0.26 (0.14–0.42) 0.77 (0.7–0.82)
ODI ≥ 5 e/h NoSAS ≥ 8 0.620 (0.531–0.709) 0.71 (0.63–0.78) 0.53 (0.4–0.65) 0.80 (0.72–0.86) 0.41 (0.30–0.52)
STOP-Bang ≥ 3 0.557 (0.464–0.650) 0.99 (0.95–1.00) 0.13 (0.06–0.24) 0.75 (0.68–0.81) 0.78 (0.45–0.94)
ESS ≥ 10 0.484 (0.392–0.575) 0.16 (0.11–0.23) 0.80 (0.68–0.88) 0.69 (0.52–0.81) 0.27 (0.2–0.34)
ODI ≥ 15 e/h NoSAS ≥ 8 0.684 (0.610–0.757) 0.87 (0.78–0.93) 0.50 (0.41–0.58) 0.52 (0.44–0.61) 0.86 (0.76–0.92)
STOP-Bang ≥ 3 0.537 (0.456–0.617) 1.00 (0.95–1.00) 0.07 (0.04–0.13) 0.41 (0.34–0.48) 1.00 (0.7–1.00)
ESS ≥ 10 0.483 (0.400–0.567) 0.15 (0.09–0.25) 0.81 (0.74–0.87) 0.34 (0.21–0.51) 0.60 (0.53–0.67)
ODI ≥ 30 e/h NoSAS ≥ 8 0.639 (0.553–0.724) 0.86 (0.73–0.94) 0.41 (0.34–0.49) 0.29 (0.22–0.38) 0.92 (0.83–0.96)
STOP-Bang ≥ 3 0.529 (0.435–0.622) 1.00 (0.92–1.00) 0.06 (0.03–0.11) 0.23 (0.18–0.29) 1.00 (0.70–1.00)
ESS ≥ 10 0.506 (0.407–0.606) 0.18 (0.1–0.32) 0.83 (0.76–0.88) 0.23 (0.12–0.39) 0.78 (0.71–0.84)
AHI apnea-hypopnea index,AUC area under the curve,CI confidence interval, e/h events/hour,NPV negative predictive value,ODI oxygen desaturation
index, PPV positive predictive value
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of 3 or 4, specific combinations of positive items should be
examined further to ensure proper classification [6]. The
NoSAS score has previously been presented as categorical
variable with various cutoff points [8, 10, 13, 14, 30].
However, according to our study results, a similar scoring
system to the STOP-Bang questionnaire can be considered.
Coutinho Costa et al. suggested a similar approach, prioritiz-
ing patients depending on their score. Patients with a score of
0–5 are to be classified as low probability of OSA—
particularly moderate to severe OSA; a score ≥ 7 are to be
classified as probable OSA; a score ≥ 12 as a high probability
of OSA—particularly moderate to severe OSA [14].
In the present cohort, male gender, age, and BMI
showed to be the strongest individual predictors for OSA
severity based on the AHI and the ODI. The discriminatory
ability of the three variables combined was similar to the
discriminatory ability of the NoSAS score and the STOP-
Bang questionnaire. In future, this might present interest-
ing opportunities to design a screening tool based on only
three variables. As an alternative, the weighing factor of
the variables gender, age, and BMI could be set higher in
the existing screening instruments. A similar approach was
suggested by Chung et al. for the STOP-Bang question-
naire, introducing male gender, BMI, and neck circumfer-
ence as high-risk variables [6].
Clinical implications
This is the first study that evaluated the predictive perfor-
mance of three different screening instruments with re-
spect to both the AHI and the ODI. This is relevant, due
to increasing evidence that the ODI has a higher repro-
ducibility in the clinical setting [19–21]. Furthermore, sig-
nificant differences in the severity of OSA have been de-
scribed between patients with a similar AHI. Presumably,
this is due to the fact that the morphology and duration of
the apneas are not taken into account in the AHI [22]. In
the present study, the NoSAS and STOP-Bang screening
instruments both have a high discriminatory ability to
predict OSA severity based on the AHI and the ODI.
The ESS, however, was not able to detect patients at high
risk for OSA and should, therefore, not be used as a
screening instrument.
AHI ≥ 5 AHI ≥ 15 AHI ≥ 30
AUC NoSAS: 0.699 (0.610-0.788) NoSAS: 0.723 (0.654-0.792) NoSAS: 0.729 (0.652-0.807)
STOP-Bang: 0.684 (0.593-0.775) STOP-Bang 0.732 (0.664-0.800) STOP-Bang 0.744 (0.668-0.821)
ESS 0.450 (0.355-0.546) ESS 0.517 (0.437-0.597) ESS 0.525 (0.431-0.619)
ODI ≥ 5 ODI ≥ 15 ODI ≥ 30
AUC NoSAS: 0.695 (0.614-0.775) NoSAS: 0.767 (0.703-0.830) NoSAS: 0.745 (0.667-0.822)
STOP-Bang: 0.689 (0.607-0.771) STOP-Bang: 0.767 (0.703-0.832) STOP-Bang: 0.737 (0.658-0.817)
ESS: 0.482 (0.391-0.572) ESS: 0.519 (0.438-0.601) ESS: 0.521 (0.422-0.619)
Fig. 1 Discriminatory ability reported as area under the curve (AUC)
(95% CI). The NoSAS score, the STOP-Bang questionnaire, and the
ESS are presented as continuous variables. OSA severity is classified
based on AHI ≥ 5 (any OSA), AHI ≥ 15 (moderate to severe OSA), and
AHI ≥ 30 (severe OSA). The ODI ≥ 3% is subdivided into ODI ≥ 5,
ODI ≥ 15, and ODI ≥ 30. The NoSAS score performed similar when
compared with the STOP-Bang questionnaire on all cutoff points (all
comparisons with p value > 0.05). The ESS presented lower discrimina-
tion than presented by the NoSAS score and the STOP-Bang question-
naire on all cutoff points (all comparisons with p value < 0.05)
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Limitations and strengths
In general, the use of a retrospective analysis to validate the
predictive value of different screening instruments is less ideal
than a prospective study. In this observational study, however,
our center had collected data prior to PSG monitoring, thus
maintaining a high credibility for this retrospective study.
Most patients were referred to the sleep clinic because they
were suspected of having sleep-related problems. Therefore, it
is possible that a selection bias was introduced, since the ques-
tionnaire was applied only to the suspected individuals. The
great prevalence of OSA in this study population could affect
the interpretation of the screening instruments. Contrarily, the
present study has several important strengths: this is the first
study that has evaluated the predictive value of different
screening instruments on the ODI. As the ODI is gaining
attention as new variable to classify OSA severity, this is an
important new insight. Furthermore, all patients were evaluat-
ed with a full PSG and scored according to the current guide-
lines proposed by the American Academy of Sleep Medicine
in 2012 [2].
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AHI ≥ 15 ODI ≥ 15
AUC Predicted probability 0.784 (0.721-0.848) Predicted probability 0.805 (0.743-0.866)
NoSAS 0.723 (0.654-0.792) NoSAS 0.767 (0.703-0.830)
STOP-Bang 0.732 (0.664-0.800) STOP-Bang 0.767 (0.703-0.832)
Fig. 2 Discriminatory ability reported as area under the curve (AUC)
(95% CI). The NoSAS score and the STOP-Bang questionnaire are pre-
sented as continuous variables. The green ROC curve shows the plotted
predicted probability of gender, age, and BMI. The predicted probability
performs similar to the NoSAS score and the STOP-Bang questionnaire
(all comparisons with p value > 0.05). The ROC curves are presented at
AHI ≥ 15 and ODI ≥ 15
1273Sleep Breath (2021) 25:1267–1275
References
1. American Academy of Sleep Medicine Task Force (1999) Sleep-
related breathing disorders in adults: recommendations for syn-
drome definition and measurement techniques in clinical research.
The Report of an American Academy of Sleep Medicine Task
Force. Sleep 22:667–689
2. Berry RB, Brooks R, Gamaldo C, Harding SM, Lloyd RM, Quan
SF, Troester MT, Vaughn BV (2017) AASM scoring manual up-
dates for 2017 (version 2.4). J Clin Sleep Med 13:665–666. https://
doi.org/10.5664/jcsm.6576
3. Muraja-Murro A, Kulkas A, Hiltunen M, Kupari S, Hukkanen T,
Tiihonen P, Mervaala E, Töyräs J (2013) The severity of individual
obstruction events is related to increased mortality rate in severe
obstructive sleep apnea. J Sleep Res 22:663–669. https://doi.org/10.
1111/jsr.12070
4. Flemons WW, Douglas NJ, Kuna ST, Rodenstein DO, Wheatley J
(2004) Access to diagnosis and treatment of patients with suspected
sleep apnea. Am J Respir Crit Care Med 169:668–672. https://doi.
org/10.1164/rccm.200308-1124pp
5. Reuveni H, Tarasiuk A, Wainstock T, Ziv A, Elhayany A, Tal A
(2004) Awareness level of obstructive sleep apnea syndrome during
routine unstructured interviews of a standardized patient by primary
care physicians. Sleep 27:1518–1524. https://doi.org/10.1093/
sleep/27.8.1518
6. Chung F, Abdullah HR, Liao P (2016) STOP-bang questionnaire a
practical approach to screen for obstructive sleep apnea. Chest 149:
631–638. https://doi.org/10.1378/chest.15-0903
7. Chung F, Yegneswaran B, Liao P, Chung SA, Vairavanathan S,
Islam S, Khajehdehi A, Shapiro CM (2008) STOP Questionnaire.
Anesthesiology 108:812–821. https://doi.org/10.1097/aln.
0b013e31816d83e4
8. Marti-Soler H, Hirotsu C, Marques-Vidal P, Vollenweider P,
Waeber G, Preisig M, Tafti M, Tufik SB, Bittencourt L, Tufik S,
Haba-Rubio J, Heinzer R (2016) The NoSAS score for screening of
sleep-disordered breathing: a derivation and validation study.
Lancet Respir Med 4:742–748. https://doi.org/10.1016/S2213-
2600(16)30075-3
9. Rebelo-Marques A, Vicente C, Valentim B, Agostinho M, Pereira
R, Teixeira MF, Moita J (2018) STOP-Bang questionnaire: the
validation of a Portuguese version as a screening tool for obstruc-
tive sleep apnea (OSA) in primary care. Sleep Breath 22:757–765.
https://doi.org/10.1007/s11325-017-1608-0
10. HongC, ChenR,Qing S, Kuang A, YangHJ, Su X, ZhaoD,WuK,
Zhang N (2018) Validation of the NoSAS score for the screening of
sleep-disordered breathing: a hospital-based retrospective study in
China. J Clin Sleep Med 14:191–197. https://doi.org/10.5664/jcsm.
6930
11. Duarte RLM, Mello FCQ, Magalhães-da-Silveira FJ, Oliveira-e-Sá
TS, Rabahi MF, Gozal D (2019) Comparative performance of
screening instruments for obstructive sleep apnea in morbidly obese
patients referred to a sleep laboratory: a prospective cross-sectional
study. Sleep Breath 23:1123–1132. https://doi.org/10.1007/
s11325-019-01791-w
12. Silva GE, Vana KD, Goodwin JL, Sherrill DL, Quan SF (2011)
Identification of patients with sleep disordered breathing: compar-
ing the four-variable screening tool, STOP, STOP-Bang, and
Epworth sleepiness scales. J Clin Sleep Med 7:467–472. https://
doi.org/10.5664/JCSM.1308
13. Tan A, Hong Y, Tan LWL, van Dam RM, Cheung YY, Lee CH
(2017) Validation of NoSAS score for screening of sleep-
disordered breathing in a multiethnic Asian population. Sleep
Breath 21:1033–1038. https://doi.org/10.1007/s11325-016-1455-4
14. Coutinho Costa J, Rebelo-Marques A, Machado JN, Gama JMR,
Santos C, Teixeira F, Moita J (2019) Validation of NoSAS (neck,
obesity, snoring, age, sex) score as a screening tool for obstructive
sleep apnea: analysis in a sleep clinic. Pulmonology 25:263–270.
https://doi.org/10.1016/j.pulmoe.2019.04.004
15. Giampá SQC, Pedrosa RP, Gonzaga CC, Bertolami A, Amodeo C,
Furlan SF, Bortolotto LA, Lorenzi-Filho G, Drager LF (2018)
Performance of NoSAS score versus Berlin questionnaire for
screening obstructive sleep apnoea in patients with resistant hyper-
tension. J Hum Hypertens 32:518–523. https://doi.org/10.1038/
s41371-018-0072-z
16. Johns MW (1991) A new method for measuring daytime sleepi-
ness: the Epworth sleepiness scale. Sleep 14:540–545. https://doi.
org/10.1093/sleep/14.6.540
17. Chiu HY, Chen PY, Chuang LP, Chen NH, Tu YK, Hsieh YJ,
Wang YC, Guilleminault C (2017) Diagnostic accuracy of the
Berlin questionnaire, STOP-BANG, STOP, and Epworth sleepi-
ness scale in detecting obstructive sleep apnea: a bivariate meta-
analysis. Sleep Med Rev 36:57–70. https://doi.org/10.1016/j.smrv.
2016.10.004
18. Duarte RLM, Magalhães-da-Silveira FJ, Oliveira-e-Sá TS, Rabahi
MF,Mello FCQ,Gozal D (2019) Predicting obstructive sleep apnea
in patients with insomnia: a comparative study with four screening
instruments. Lung 197:451–458. https://doi.org/10.1007/s00408-
019-00232-5
19. Tkacova R, McNicholas WT, Javorsky M, Fietze I, Sliwinski P,
Parati G, Grote L, Hedner J (2014) Nocturnal intermittent hypoxia
predicts prevalent hypertension in the European Sleep Apnoea
Database cohort study. Eur Respir J 44:931–941. https://doi.org/
10.1183/09031936.00225113
20. Vos P. Richtlijn obstructief slaapapneu (OSA) bij volwassenen
21. Nieto FJ, Young TB, Lind BK (2000) Association of sleep-
disordered breathing, sleep apnea, and hypertension in a large
community-based study. JAMA 283:1829–1836. https://doi.org/
10.1001/jama.283.14.1829
22. Kulkas A, Tiihonen P, Julkunen P, Mervaala E, Töyräs J (2013)
Novel parameters indicate significant differences in severity of ob-
structive sleep apnea with patients having similar apnea-hypopnea
index. Med Biol Eng Comput 51:697–708. https://doi.org/10.1007/
s11517-013-1039-4
23. Temirbekoy D, Gunes S, Yazici ZM, Sayin İ (2018) The ignored
parameter in the diagnosis of obstructive sleep apnea syndrome the
oxygen desaturation index. Turk Otolarengoloji Arsivi/Turkish
Arch Otolaryngol:1–6. https://doi.org/10.5152/tao.2018.3025
24. Fietze I, Dingli K, Diefenbach K, Douglas NJ, Glos M, Tallafuss
M, Terhalle W, Witt C (2004) Night-to-night variation of the oxy-
gen desaturation index in sleep apnoea syndrome. Eur Respir J 24:
987–993. https://doi.org/10.1183/09031936.04.00100203
25. Tsai CM, Kang CH, Su MC, Lin HC, Huang EY, Chen CC, Hung
JC, Niu CK, Liao DL, Yu HR (2013) Usefulness of desaturation
index for the assessment of obstructive sleep apnea syndrome in
children. Int J Pediatr Otorhinolaryngol 77:1286–1290. https://doi.
org/10.1016/j.ijporl.2013.05.011
26. Levendowski DJ, Hamilton GS, St. Louis EK, Penzel T, Dawson
D, Westbrook PR (2019) A comparison between auto-scored ap-
nea-hypopnea index and oxygen desaturation index in the charac-
terization of positional obstructive sleep apnea. Nat Sci Sleep 11:
69–78. https://doi.org/10.2147/NSS.S204830
27. Chung F, Liao P, Elsaid H, Islam S, Shapiro CM, Sun Y (2012)
Oxygen desaturation index from nocturnal oximetry: a sensitive
and specific tool to detect sleep-disordered breathing in surgical
patients. Anesth Analg 114:993–1000. https://doi.org/10.1213/
ANE.0b013e318248f4f5
28. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M,
Obuchowski N, Pencina MJ, Kattan MW (2010) Assessing the
performance of prediction models: a framework for traditional
and novel measures. Epidemiology 21:128–138. https://doi.org/
10.1097/EDE.0b013e3181c30fb2
1274 Sleep Breath (2021) 25:1267–1275
29. Hanley JA, McNeil BJ (1982) The meaning and use of the area
under a receiver operating characteristic (ROC) curve. Radiology
143:29–36. https://doi.org/10.1148/radiology.143.1.7063747
30. Guichard K, Marti-Soler H, Micoulaud-Franchi JA, Philip P,
Marques-Vidal P, Vollenweider P, Waeber G, Preisig M, Haba-
Rubio J, Heinzer R (2018) The NoSAS score: a new and simple
screening tool for obstructive sleep apnea syndrome in depressive
disorder. J Affect Disord 227:136–140. https://doi.org/10.1016/j.
jad.2017.10.015
Publisher’s note Springer Nature remains neutral with regard to jurisdic-
tional claims in published maps and institutional affiliations.
1275Sleep Breath (2021) 25:1267–1275
